New York, New York (PRWEB) May 28, 2014
The Executing Global Clinical Trials conference announced today that the voice of the patient in shaping global clinical trials is central to the 5th annual event. “Making global trials easier for patients and sites is critical to the future of drug development,” says, Kristen Pisanelli, Conference Producer.
The Multi-Regional Clinical Trials Center at Harvard, NPS Pharma, and Bayer Healthcare lead discussions on the development of patient-centric global protocols as well as how to work with patient advocacy groups and incorporate investigator and patient feedback into study designs on September 10th, 2014 at the Fairmont Copley Plaza in Boston, MA.
Vertex Pharmaceuticals is confirmed to lead a talk on driving faster patient access in global trials and Purdue Pharma, along with Trevi Therapeutics, team up to give a session on rethinking best practices to partner with global investigative sites.
Global clinical trial veteran Christopher Gallen, CEO, SK Biopharmaceuticals, chairs the conference, which kicks off with a featured presentation by Thomas Lonngren, former Head of EMA, and also includes a risk-based monitoring case study by Quintiles.
“The constant change in technology in our industry makes global clinical trials interesting and challenging, but the core issues remain: finding and retaining patients, and ensuring quality control,” says Thomas Haag, Data Integrity Process Expert at Novartis, and conference advisor.
The Global Clinical Trials conference offers concrete topics impacting management of clinical studies globally by finding the right balance between recruitment, cost savings, future regulatory obligations, and managing relationships with global service providers. This conference is offered as a one-day event, or can be combined with the Disruptive Innovations to Advance Clinical Trials conference on September 11-12 in the same venue.
About The Conference Forum
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.